BETSUNOU HIRONORI

Profiles

Profiles

• 氏名

  BETSUNOU HIRONORI

Affiliation

• Department of Urology

Research achievements

Published Papers

Original paper
• 5(1), e000666, Jan. 2018

  DOI
• 17(1), 47, Jun. 2017

  DOI
• 11, 47-49, Jan. 2017

  DOI
• Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer, Mizuno T, Kamai TAbe HSakamoto SKitajima KNishihara DYuki HKambara TBetsunoh HYashi MFukabori YKaji YYoshida K, BMC Cancer, 15, 1097, 2015

  DOI
• Metronomic oral cyclophosphamide chemotherapy possibly contributes to stabilization of disease in patients with metastatic castration-resistant prostate cancer: a prospective analysis of consecutive cases, Yashi M, Nishihara DMizuno TYuki HMasuda AKambara TBetsunoh HAbe HFukabori YMuraishi OKamai T, Clin Genitourin Cancer, 12(5), e197-e203, Oct. 2014

  DOI
• Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy, Yashi M, Mizuno TYuki HMasuda AKambara TBetsunoh HAbe HFukabori YMuraishi OSuzuki KNakazato YKamai T, BMC Urol, 14, 43, 2014

  DOI
• Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report, Yuki H, Kamai TKubota KAbe HNishihara DMizuno TMasuda ABetsunoh HYashi MFukabori YYoshida K, Onco Targets Ther, 7, 289-295, 2014

  DOI
• Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma, Masuda A, Arai KNishihara DMizuno TYuki HKambara TBetsunoh HAbe HYashi MFukabori YYoshida KKamai T, Biomed Res Int, 2014, 396064, 2014

  DOI
• The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells, Abe H, Kamai THayashi KAnzai NShirataki HMizuno TYamaguchi YMasuda AYuki HBetsunoh HYashi MFukabori YYoshida K, BMC Cancer, 14, 412, 2014

  DOI
• 2(3), 122, Dec. 2013

  DOI
• Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma, Betsunoh H, Fukuda TAnzai NNishihara DMizuno TYuki HMasuda AYamaguchi YAbe HYashi MFukabori YYoshida KKamai T, BMC Cancer, 13, 509, 2013

  DOI
• Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma, Betsunoh H, Mukai SAkiyama YFukushima TMinamiguchi NHasui YOsada YKataoka H, Cancer Sci, 98(4), 491-498, Apr. 2007

  DOI
• Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations, Hamasuna R, Betsunoh HSueyoshi TYakushiji KTsukino HNagano MTakehara TOsada Y, Int J Urol, 11(11), 941-947, Nov. 2004

  DOI
• 24(1), 61-63, Mar. 2015
• 27(8), 1271-1273, Aug. 2014
• 24(1), 148-152, Jun. 2013
• Clinical Significance of 18F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma., Betsunoh Hironori;Sakamoto Setsu;Kaji Yasushi;Nukui Akinori;Kobayashi Minoru;Yashi Masahiro;Hayashi Keitaro;Anzai Naohiko;Kamai Takao, Anticancer research, 41(10), 5179-5188, Oct. 2021

  DOIPermalink
• Distribution of the positive UPOINT domain in patients with chronic prostatitis or chronic pelvic pain syndrome: A multicenter observational study., Ichihara Koji;Takahashi Satoshi;Hiyama Yoshiki;Masumori Naoya;Nagae Hiroshi;Ito Shin;Wada Koichiro;Betsunoh Hironori;Hamasuna Ryoichi;Togo Yoshikazu;Shigemura Katsumi;Takeyama Ko, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 28(5), 631-634, May 2022

  DOIPermalink
• Transperitoneal laparoscopic umbilical resection of urachal remnants: a feasible surgical method., Yuki Hideo;Ohkubo Naoya;Kurashina Ryo;Sakamoto Kazumasa;Suzuki Issei;Takei Kohei;Betsunoh Hironori;Nukui Akinori;Yashi Masahiro;Kamai Takao, BMC urology, 23(1), 57, 04 Apr. 2023

  DOI
• Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients., Takei Kohei;Kijima Toshiki;Okubo Naoya;Kurashina Ryo;Kokubun Hidetoshi;Uematsu Toshitaka;Betsunoh Hironori;Yashi Masahiro;Kamai Takao, Cancers, 15(23), 26 Nov. 2023

  DOI

Case report
• Metastasis of malignant melanoma to urinary tract: a case report., Ueno Takashi;Kiwaki Takumi;Betsunoh Hironori;Ito Kaoru;Murashima Takaya;Fujii Masato;Nagai Takahiro;Mukai Shoichiro;Sawada Atsuro;Kamoto Toshiyuki, Journal of medical case reports, 18(1), 396, 28 Aug. 2024

  DOI

Other
• 24(1), 148-152, Jun. 2013
• 3(4), 417, Apr. 2010
• 28(1), 57-58, Jan. 2015
• 68(9), 658-660, Aug. 2014
• 67(1), 27-33, Jan. 2013
• 68(9), 658-660, Aug. 2014

Presentations

• FGF7 as a candidate urine biomarker for prostate cancer detection., Fukabori Y, Yamazaki H, Yanagibayashi A, Yashi M, Abe H, Betsunoh H, Masuda A, Yuki H, Arai K, Kamai, Apr. 2014, Poster presentation, The 29th Annual Congress of the European Association of Urology, True
• A practical training system of laparoscopic surgery, Yuki H, Nishihara D, Fuse M, Mizuno T, Masuda A, Betsuno H, Abe H, Yashi M, Fukabori Y, Yamanishi T, Yoshida K-I, Kamai T, Oct. 2013, Poster presentation, 31st world congress of endourology&SWL, True